These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2590464)

  • 21. Demonstration of the existence of a second, non-lysosomal glucocerebrosidase that is not deficient in Gaucher disease.
    van Weely S; Brandsma M; Strijland A; Tager JM; Aerts JM
    Biochim Biophys Acta; 1993 Mar; 1181(1):55-62. PubMed ID: 8457606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Destruction and resynthesis of mouse beta-glucosidases.
    Hara A; Radin NS
    Biochim Biophys Acta; 1979 Feb; 582(3):412-22. PubMed ID: 33720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and characterization of bovine brain glucocerebrosidase.
    Reddy PU; Murray GJ; Barranger JA
    Biochem Med; 1985 Apr; 33(2):200-10. PubMed ID: 4004822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Function of oligosaccharide modification in glucocerebrosidase, a membrane-associated lysosomal hydrolase.
    Van Weely S; Aerts JM; Van Leeuwen MB; Heikoop JC; Donker-Koopman WE; Barranger JA; Tager JM; Schram AW
    Eur J Biochem; 1990 Aug; 191(3):669-77. PubMed ID: 2143986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucosylceramidase from calf spleen. Characterization of its active site with 4-n-alkylumbelliferyl beta-glucosides and N-alkyl derivatives of 1-deoxynojirimycin.
    Legler G; Liedtke H
    Biol Chem Hoppe Seyler; 1985 Dec; 366(12):1113-22. PubMed ID: 2936366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An endogenous activator protein in human placenta for enzymatic degradation of glucosylceramide.
    Vaccaro AM; Muscillo M; Gallozzi E; Salvioli R; Tatti M; Suzuki K
    Biochim Biophys Acta; 1985 Sep; 836(2):157-66. PubMed ID: 4027262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of activation of glucocerebrosidase by co-beta-glucosidase (glucosidase activator protein).
    Berent SL; Radin NS
    Biochim Biophys Acta; 1981 Jun; 664(3):572-82. PubMed ID: 6268176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of human glucosylsphingosine glucosyl hydrolase and comparison with glucosylceramidase.
    Vaccaro AM; Muscillo M; Suzuki K
    Eur J Biochem; 1985 Jan; 146(2):315-21. PubMed ID: 3967661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease.
    van Weely S; van den Berg M; Barranger JA; Sa Miranda MC; Tager JM; Aerts JM
    J Clin Invest; 1993 Mar; 91(3):1167-75. PubMed ID: 8450045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variable expression of leukocyte cytosolic broad-specificity beta-glucosidase activity.
    Forsyth GW; Romero KM; Alverson J; VanderJagt DJ; Glew RH
    Clin Chim Acta; 1993 Jul; 216(1-2):11-21. PubMed ID: 8222261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity of human glucosylceramide beta-glucosidase towards synthetic glucosylsphingolipids inserted into liposomes. Kinetic studies in a detergent-free assay system.
    Sarmientos F; Schwarzmann G; Sandhoff K
    Eur J Biochem; 1986 Nov; 160(3):527-35. PubMed ID: 3780720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gaucher-like changes in human blood-derived macrophages induced by beta-glucocerebrosidase inhibition.
    Yatziv S; Newburg DS; Livni N; Barfi G; Kolodny EH
    J Lab Clin Med; 1988 Apr; 111(4):416-20. PubMed ID: 3351378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitor screening of pharmacological chaperones for lysosomal β-glucocerebrosidase by capillary electrophoresis.
    Shanmuganathan M; Britz-McKibbin P
    Anal Bioanal Chem; 2011 Mar; 399(8):2843-53. PubMed ID: 21286689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysosomal beta-glucosidase of rat liver.
    Fabbro D; Desnick RJ; Gatt S
    Enzyme; 1984; 31(2):122-7. PubMed ID: 6426948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of specific deoxynojirimycin-type inhibitors of the non-lysosomal glucosylceramidase.
    Overkleeft HS; Renkema GH; Neele J; Vianello P; Hung IO; Strijland A; van der Burg AM; Koomen GJ; Pandit UK; Aerts JM
    J Biol Chem; 1998 Oct; 273(41):26522-7. PubMed ID: 9756888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucosylceramide and glucosylsphingosine metabolism in cultured fibroblasts deficient in acid beta-glucosidase activity.
    Sasagasako N; Kobayashi T; Yamaguchi Y; Shinnoh N; Goto I
    J Biochem; 1994 Jan; 115(1):113-9. PubMed ID: 8188616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholesterol glucosylation is catalyzed by transglucosylation reaction of β-glucosidase 1.
    Akiyama H; Kobayashi S; Hirabayashi Y; Murakami-Murofushi K
    Biochem Biophys Res Commun; 2013 Nov; 441(4):838-43. PubMed ID: 24211208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectors of three beta-glucosidases from human liver.
    Daniels LB; Gnarra JR; Glew RH
    Prog Clin Biol Res; 1982; 95():333-55. PubMed ID: 6812077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of activator proteins for the enzymatic degradation of glucosylceramide in several human tissues.
    Vaccaro AM; Ciaffoni F; Mandara I; Suzuki K
    Clin Chim Acta; 1988 Mar; 172(2-3):323-34. PubMed ID: 3370844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Klotho-related protein is a novel cytosolic neutral beta-glycosylceramidase.
    Hayashi Y; Okino N; Kakuta Y; Shikanai T; Tani M; Narimatsu H; Ito M
    J Biol Chem; 2007 Oct; 282(42):30889-900. PubMed ID: 17595169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.